Objective: To determine if reduction in nitric oxide bioactivity contributes to the physiological instability that occurs after brain death and, if so, to also determine in this setting whether administration of a renitrosylating agent could improve systemic physiological status. Background: Organ function after brain death is negatively impacted by reduced perfusion and increased inflammation; the magnitude of these responses can impact post-graft function. Perfusion and inflammation are normally regulated by protein S-nitrosylation but systemic assessments of nitric oxide bioactivity after brain death have not been performed. Methods: Brain death was induced in instrumented swine by inflation of a balloon catheter placed under the cranium. The subjects were then serially assigned to receive either standard supportive care or care augmented by 20 ppm of the nitrosylating agent, ethyl nitrite, blended into the ventilation circuit. Results: Circulating nitric oxide bioactivity (in the form of S-nitrosohemoglobin) was markedly diminished 10 hours after induction of brain death-a decline that was obviated by administration of ethyl nitrite. Maintenance of S-nitrosohemoglobin was associated with improvements in tissue blood flow and oxygenation, reductions in markers of immune activation and cellular injury, and preservation of organ function. Conclusions: In humans, the parameters monitored in this study are predictive of post-graft function. As such, maintenance of endocrine nitric oxide bioactivity after brain death may provide a novel means to improve the quality of organs available for donation.
hrsa.gov/). Five-year survival rates for recipients of these organs range from 80% for kidneys to just over 50% for lungs; where comparisons can be made (kidney, liver), survival rates are significantly higher for those patients who received their new organ from a living donor. 1, 2 Stressors placed upon organs, particularly brain death, are believed to contribute to these survival rate differences. Stressors are also significant contributors to the poor procurement rate of suitable organs from consented donors (<50%) due primarily to in-situ organ failure. 3 The period during and after brain death is characterized by physiological instability, the result first of intense sympathetic stimulation and significant release of catecholamines (the Cushing response) with transient vasoconstriction, hypertension, and tachycardia, followed by the complete loss of sympathetic activity, leading to hypotension and a profound reduction in systemic vascular resistance. 4 Hemodynamic homeostasis is regulated in part by nitric oxide. 5 A disruption of endocrine nitric oxide bioactivity may contribute to the tissue ischemia and organ damage that has previously been ascribed to loss of autonomic function. Post-brain death organ function can be further impaired by an inflammatory state, 6 and this too may reflect a deficiency of nitric oxide. 7 Once brain death is confirmed, care of the patient switches from restorative to supportive as organ donation status is assessed. 8 Supportive care aims to maintain organ perfusion and, to some extent, the acidosis and systemic effects of brain death can be controlled by altering ventilation rates and/or administration of vasoactive agents. However, such interventions may have minimal ability to preserve end-organ oxygen delivery, which is primarily a function of local tissue perfusion. Local blood flow is "autoregulated" at least in part through nitric oxide bioactivity derived from red blood cells. 9, 10 Hemoglobin plays a central role in this autoregulation by coupling the binding and release of oxygen with that of nitric oxide. 11 Hypoxic vasodilation by red blood cells is linked to hemoglobin desaturation, which effects the release of nitric oxide from thiols of hemoglobin (S-nitrosohemoglobin), thereby providing a regulated mechanism for matching blood flow (oxygen delivery) with local metabolic demand. 5 Decreased levels and/or impaired processing of S-nitrosohemoglobin have been observed in diseases characterized by tissue hypoxemia [12] [13] [14] [15] [16] [17] [18] ; where examined, red blood cells from these disparate patient populations exhibited impaired vasodilatory capacity. Such data suggest that red blood cell-derived nitric oxide bioactivity may play an important role in the respiratory cycle, and that impairment of this activity might contribute to the pathophysiology of ischemic conditions. Based on these findings, we reasoned that a similar disruption of this endocrine function of red blood cells might occur after cessation of central nervous system activity, thus contributing to systemic hemodynamic instability. We further reasoned that in this setting an intervention directed toward increasing nitric oxide bioactivity could be beneficial.
Surgical Instrumentation
Animals were sedated with acepromazine (0.8 mg/kg) and ketamine (20 mg/kg; both im), then anesthesia was induced with thiopental (10 mg/kg, iv). After endotracheal intubation, anesthesia was maintained with isoflurane (1.5-2.0%). Ventilatory settings were adjusted to maintain end-tidal carbon dioxide below 35 mm Hg. Isoflurane and end-tidal carbon dioxide concentrations were continually measured by an airway gas monitor (Datex Instrumentation Corporation, Helsinki, Finland). Body temperature was maintained at 38 (±0.5)
• C with a Bair-Hugger warming system (Arizant Healthcare Incorporated, Eden Prairie, MN). Electrocardiography leads were placed, vascular access was obtained at various sites (the right internal jugular for the central line, the femoral artery and vein for the peripheral lines), and bladder access was secured through a peritoneal incision. Hemodynamic parameters (cardiac output, arterial pressures, etc) were monitored using a vigilance system from Edwards Lifesciences (Irvine, CA). After revealing the scalp, a small hole was bored for placement of an intracranial pressure probe (Aesculap Inc. USA, Center Valley, PA) and a forehead sensor was placed to monitor brain electrical activity (Aspect Medical Systems, Inc., Norwood, MA). A second trepanation was conducted for insertion of a balloon catheter.
Brain Death
Brain death was induced by inflation of the balloon catheter over a period of 10 to 15 minutes until intracranial pressure exceeded systolic blood pressure. This state of elevated intracranial pressure was maintained throughout the study to keep cerebral perfusion pressure at 0 mm Hg. Loss of brain electrical activity was confirmed and then the vaporizer was turned off. When expired isoflurane concentration reached 0, a brain death assessment was conducted (pupils fixed and nonreactive to light, no lash or corneal touch response, absent oculocephalic reflex, absent vestibulo-ocular reflex after auricular washing with cold saline, no gag reflex, and no cough with tracheal suction). A ventilatory drive test was not conducted because we determined during model development that this procedure induced cardiac instability. Ethyl nitrite treatment was begun after confirmation of brain death and continued for 10 hours. Cardiac instability was treated with fluids and pharmacologic therapy 19 ; hormone replacement was not initiated. Ventricular fibrillation refractory to electrocardioversion was the cause for early study termination.
Physiological Analyses
Tissue oxygenation and tissue hemoglobin levels (the latter serving as a surrogate for tissue blood flow) were measured in the buccal mucosa using a spectrophotometric monitoring system (T-Stat; Spectros Corporation, Portola Valley, CA). 20 Arterial and venous blood gas parameters were measured at 60-minute intervals during the study using a Gem Premier 3000 (Instrumentation Laboratory, Lexington, MA). Additional venous blood samples were collected before and then again 10 hours after the determination of brain death for clinical chemistry analyses (Antech Diagnostic, Cary, NC) and for determination of red blood cell S-nitrosohemoglobin levels, the latter using mercury-coupled photolysis-chemiluminescence. 21, 22 Glomerular filtration rate was estimated from the serum chemistry data using the following formula: 170
+0.318 , modified from Levey et al. 23 Inulin clearance was another method used to measure kidney function: 60 mg/kg of inulin (Alfa Aesar, Ward Hill, MA) in 250 mL of normal saline was rapidly infused (iv), urine was collected for 1 hour, and at the end of this collection period, a venous blood sample was obtained; inulin clearance assessments were also conducted before and then started 9 hours after brain death to account for the 60-minute interval between inulin infusion and blood/urine collection. Blood and urine inulin levels were then quantitated using an established chromatographic method.
24,25

Statistical Analyses
Data are presented as means ± standard deviations except for changes in oxygen content, which are presented as medians ± firstand third-quartile deviations. For finite parameters, testing involved paired t tests to determine differences before and after brain death; where significant changes were identified, analysis of variance was used to test if the magnitudes of the changes were different between groups.
To determine change in oxygen utilization, arterial and venous blood oxygen contents were calculated using the standard clinical formula ([blood oxygen saturation × hemoglobin × 1.34] + [0.003 × blood oxygen partial pressure]), from which the difference was determined by subtracting the venous value from the arterial value. Subsequent changes in the arterial/venous difference were determined by subtraction: arterial/venous experiment -arterial/venous baseline . Positive values indicate a decrease in venous blood oxygen content and thus an increase in oxygen utilization because arterial oxygen content was essentially constant; negative values reflect an increase in venous blood oxygen content and thus a reduction in oxygen utilization.
For continual parameters, median values were calculated at 60-minute intervals and averaged to obtain group data for presentation. Area under the curve values for the percentage of change from the baseline of tissue oxygenation and tissue-hemoglobin, and of the arterial/venous differences were calculated and then tested for treatment effects using analysis of variance. The Tukey test was used to identify group differences when the F statistic was significant. Linear regression, where noted, was conducted to test for temporal relationships. Comparisons were made using the Prism Graphpad software package (Graphpad, La Jolla, CA); P values of < 0.05 were considered significant.
RESULTS
General Physiological Status
A total of 39 adult swine were utilized for this study: 16 were employed for model development and initial ethyl nitrite dose titration assessments, 3 developed intractable ventricular fibrillations and cessation of cardiac activity after induction of brain death but before the end of the study (2 in the control group and 1 in the ethyl nitrite group), and 20 completed the study (n = 10 per group). Data on the cardiovascular status for these latter swine are presented in Figure 1 . Parameters for all animals that completed the study met the United Network for Organ Sharing guidelines, specifically cardiac output was > 3.8 L/minute and mean arterial pressure was > 60 mm Hg. Ventilation was actively regulated to keep end-tidal carbon dioxide below 35 mm Hg and the partial pressure of arterial oxygen/fractional inspired oxygen ratio significantly higher than 300 mm Hg (data depicted in the Supplemental Digital Content Figure 1 , http://links.lww. com/SLA/A347). FIGURE 1. Cardiovascular status. Mean (± standard deviation) time courses for cardiac output, mean arterial pressure, and heart rate after the determination of brain death for the untreated (solid line) and ethyl nitrite-exposed (dashed line) cohorts. Within each graph, baseline mean (± standard deviation) values are depicted by the bar and arrows. These parameters met the United Network for Organ Sharing guidelines for donor maintenance with cardiac output > 3.8 L/min and mean arterial pressure > 60 mm Hg. Assessing for cardiovascular treatment differences was not a component of this study.
cohort, S-nitrosohemoglobin concentrations declined from 0.52 ± 0.68 to 0.21 ± 0.22 moles of S-nitrosothiol per moles of hemoglobin tetramer × 10 −3 (P = 0.04 paired t test; n = 8, with 2 samples lost during processing), whereas there was minimal decline in S-nitrosohemoglobin in the 20-ppm ethyl nitrite cohort (from 0.38 ± 0.64 to 0.35 ± 0.15 S-nitrosothiol per hemoglobin tetramer × 10 −3 ; P > 0.05, n = 9, with 1 sample lost during processing). The decline in S-nitrosohemoglobin in the control group was associated with alterations in oxygen utilization and local blood flow (Fig. 2) , as demonstrated by the changes from baseline in arterial/venous oxygen content differences and buccal skeletal muscle bed tissue oxygenation and tissue-hemoglobin values. In the control group, the changes in the arterial/venous difference after brain death were negative, indicative of a rise in venous oxygen content. This was accompanied by and correlated with (P < 0.001) declines in both tissue oxygenation and tissue blood flow (ie, a reduction in tissue hemoglobin). Ethyl nitrite treatment reversed these effects: the arterial/venous oxygen content difference was greater after brain death (ie, venous blood oxygen content declined), and tissue oxygenation and tissue blood flow increased. Similar to the control group, the changes in arterial/venous oxygen content correlated with tissue oxygenation and tissue blood flow (P < 0.001). Area under the curve comparisons determined that the 3 parameters were all significantly different between the control and the 20-ppm ethyl nitrite group (P = 0.028, P = 0.0037, and P = 0.021 for arterial/venous content, tissue oxygenation, and tissue hemoglobin, respectively).
Metabolic Parameters
Values for various serum enzymes and metabolic markers before and 10 hours after confirmation of brain death are presented in Table 1 . (Additional serum chemistry results can be found in the Supplemental Digital Content Table 1 , http://links.lww.com/SLA/A347) Changes were most notable in the control group. Serum glucose levels increased, presumably reflecting an increase in glycogenolysis. 26 Total protein decreased, which, along with the changes in serum electrolytes and increase in urine volume, is indicative of induction of diabetes insipidus. 27 Lipase (but not amylase or alkaline phosphatase) increased in both groups. Markers of liver (alanine aminotransferase, aspartate aminotransferase), kidney (creatinine), and tissue (creatine phosphokinase) injury were all significantly elevated in the control animals. Although aspartate aminotransferase and creatine phosphokinase also increased in the ethyl nitrite group, the magnitudes of these increases were significantly smaller. Modest elevations in hematocrit and hemoglobin levels occurred in both groups. White blood cell counts only rose in the control group, which represented statistically significant increases in circulating neutrophils and monocytes.
Kidney Function
Glomerular filtration rate and inulin clearance were assessed before and after brain death, with clearance calculated as the plasmato-urine-inulin concentration ratio. These parameters, along with mean serum creatinine levels, are presented in Figure 3 . In the control group, the mean inulin-to-plasma ratio increased significantly 10 hours after brain death (from 0.15 to 1.89; P = 0.011 paired t test). This was accompanied by a significant decline in the glomerular filtration rate (from 102 ± 13 to 77 ± 18 arbitrary units; P = 0.0009) and a significant increase in the serum creatinine concentration (P = 0.02). In contrast, neither the before/after inulin ratios (0.21 vs 0.17; P = 0.49) nor the glomerular filtration rate (91 ± 15 vs. 84 ± 22; P = 0.10) was different in the 20-ppm ethyl nitrite group, nor was there a change in the treated subjects' serum creatinine concentrations (P = 0.90).
DISCUSSION
Altered levels of S-nitrosothiol and impaired vasodilatory activity of red blood cells have been observed in several chronic disease states characterized by aberrant tissue oxygenation. More recently, it has become apparent that various medical interventions, including blood transfusion 28 and peritoneal insufflation with carbon dioxide, 29 can adversely affect red blood cell nitric oxide bioactivity, with resultant reductions in organ blood flow. On the basis of the present results, brain death may constitute an acute stress characterized by relatively rapid reductions in S-nitrosohemoglobin (ie, within 10 hours), leading to decreases in oxygen utilization (Fig. 2) . Our data thus provide a new perspective on the peripheral response to cessation of central nervous system activity in which the sequelae represent a systemwide failure of microvascular oxygen delivery rather than a disparate collection of failing organs. The mechanism to account for the depletion of S-nitrosohemoglobin after brain death is probably multifold. Increasing acidosis disfavors the binding of nitric oxide to the beta cysteine residue of hemoglobin. 21 The post-brain death catecholamine surge, with resultant vasoconstriction and progressive lung injury, may also contribute to this decline through effects on hemoglobin oxygenation. Data on S-nitrosohemoglobin (moles of SNO per moles of Hb tetramere × 10 −3 ) along with various serum enzymes and metabolic markers before and 10 hours after determination of brain death for the 2 experimental groups. Values in the "after" columns that are followed by an asterisk ( * ) indicate a significant difference from the pre-brain death values (P < 0.05). Values in the "after" column of the control group also followed by a dagger ( †) indicate that the magnitude of the increase was significantly larger than the change observed in the ENO treatment group (again, P < 0.05).
ENO indicates ethyl nitrite; SNO-Hb, S-nitrosohemoglobin; Alk., alkaline; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CPK, creatine phosphokinase.
The inability of S-nitrosohemoglobin-depleted red blood cells to facilitate hypoxic vasodilation has been well documented 16, 28, 30 and thus provides a potential therapeutic target. Indeed, nitrosylating therapies directed toward increasing S-nitrosohemoglobin have recently been developed and have shown therapeutic potential. In particular, ethyl nitrite has been shown to correct impairments in tissue perfusion in a number of clinical and preclinical conditions that have in common a depletion of S-nitrosohemoglobin. 16, 29, [31] [32] [33] [34] In the present setting, inhalation of ethyl nitrite after brain death restored S-nitrosohemoglobin concentration, enhanced tissue oxygenation and blood flow, and reduced markers of injury and inflammation. Collectively, these measures of organ viability are predictive of post-graft function. 35 Particularly notable were the effects of ethyl nitrite on kidney function where 10 hours after brain death, no significant changes were seen in inulin clearance, glomerular filtration rate, or serum creatinine concentration (Fig. 3) . In the control group, the >0.3 mg/dL increase in creatinine concentration (Table 1 ) meets the criteria for diagnosing acute kidney injury. 36 Serum creatinine can increase during donor support, 37 with some authors reporting >20% elevations (a level observed in our study) in more than 40% of human donors prior to organ procurement. 38 Elevated donor creatinine and reduced glomerular filtration rate are significant risk factors for delayed graft function and graft failure in kidney transplant recipients. 39 The major nondrug-based cause of acute kidney injury is renal hypo-perfusion, 40 which implies there were differences in kidney blood flow between the 2 experimental groups. Ethyl nitrite increased buccal blood flow (Fig. 2) , a finding that is consistent with our previous work demonstrating that this agent can maintain flow to multiple organs. 29 As such, our data support the notion that brain death-induced perturbations in blood flow to the kidneys (and to other organs) are reversed by inhalation of ethyl nitrite.
Nitrosylation therapy with ethyl nitrite may confer additional benefits. Hemoglobin is the major target of inhaled ethyl nitrite but S-nitrosohemoglobin can exchange nitric oxide with other proteins via transnitrosylation reactions to distribute nitric oxide bioactivity in vivo. 41 Under normal conditions, the activities of many inflammatory and proapoptotic proteins, including toll-like receptors, interleukins, tumor necrosis factors, caspases, etc., are tightly controlled by S-nitrosylation [42] [43] [44] ; their subsequent overexpression after loss of central nervous system function [45] [46] [47] [48] may well reflect a loss of this regulatory control and are thus potential targets for ethyl nitrite. Indeed, administration of a nitrosylating agent (or an exogenous S-nitrosothiol) can produce beneficial results in a number of acute and chronic inflammatory conditions where S-nitrosothiol levels are reduced. [49] [50] [51] [52] [53] [54] Because neutrophil infiltration appears to negatively impact post-graft function, 55 a more in-depth elucidation of ethyl nitrite's actions on the inflammatory cascade after brain death would be worthwhile. In addition, nitrosylating therapy may also provide the means to enhance the activities of protective genes such as HIF- 1 56 and HO-1 57 (a more selective approach than present therapies such as using dopamine to induce HO-1 activity 58 ). With respect to recording blood flow and tissue oxygenation, we selected the buccal mucosa as a monitoring site because this location allowed for easy sensor placement and provided for continued access in case of displacement. Previous studies with the T-Stat have demonstrated that recorded measurements from the buccal mucosa correlate well with recordings from more invasive locations, and that changes in buccal mucosa oxygen levels and blood flow are sensitive indicators of global oxygenation status. 20 In addition, it has long been recognized that the external carotid arteries can remain well perfused after brain death, even as blood flow within the internal carotids is significantly impaired. 59 Although additional testing is needed, the present findings suggest that this site may be a convenient location to monitor perfusion changes during donor support.
Our study has limitations. The method of brain death induction was rapid, whereas in humans, there can be a more delayed increase in intracranial pressure and this can subsequently alter the pattern of systemic organ disruption. 60 We were not in a position to conduct histological assessments to determine if the functional benefits of ethyl nitrite also prevented structural damage. The period of monitoring was short compared with the interval between declaration of death and organ procurement for some brain-dead human donors. Nonetheless, it is doubtful that the observed depletion of S-nitrosohemoglobin Copyright © 2013 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
FIGURE 2.
Oxygen utilization and tissue oxygenation. Median (± quartile deviation) changes in arterial/venous oxygen content differences along with mean (± standard deviation) tissue oxygenation and tissue hemoglobin (a measure of blood flow) percent changes from baseline after the determination of brain death for the untreated (solid line) and ethyl nitrite-exposed (dotted line) cohorts. Arterial/venous values were determined by the formula arterial/venous experimental -arterial/venous baseline . Negative values, as seen in the control group, reflect an increase in venous blood oxygen content after brain death and thus a reduction in oxygen utilization because arterial oxygen content was constant. The positive values, as seen with the ethyl nitrite treatment, indicate a decrease in venous blood oxygen content and thus an increase in oxygen utilization. Tissue oxygenation and tissue hemoglobin were both significantly increased by 20 ppm ethyl nitrite compared with the control values.
in the standard therapy control group would have resolved if the experimental duration increased. We deliberately chose to not initiate any hormone therapy so as to focus on documenting the effects of ethyl nitrite inhalation. As administration of vasopressin, thyroxine, insulin, etc. to human donors may confer benefits with respect to postgraft function, 61 it is tempting to speculate that such benefits could be augmented when nitric oxide bioactivity levels are maintained after brain death.
In summary, inhalation of the S-nitrosylating agent ethyl nitrite is an effective means to attenuate brain death-induced reductions in S-FIGURE 3. Kidney function and serum creatinine. Mean (± standard deviation) serum creatinine (top panel), calculated individual glomerular filtration rates (middle panel), and individual inulin plasma/urine ratios (bottom panel) before and 10 hours after determination of brain death. The group means for glomerular filtration rates and inulin ratios are demarcated with bars. Serum creatinine and the plasma/urine inulin ratios significantly increased and glomerular filtration rates significantly decreased in the untreated control cohort after brain death (P < 0.05; brackets with asterisks). In the 20-ppm ethyl nitrite treatment group, the before and after brain death values for all 3 parameters were not statistically different.
nitrosohemoglobin concentrations, maintain tissue oxygenation, and reduce tissue injury, inflammation, and organ damage. As a result, clinical assessments of the utility and benefits of this intervention may be warranted. More generally, the present findings further support the importance of endocrine nitric oxide bioactivity in the regulation of organ function and they provide a novel example in which aberrant S-nitrosylation can be reversed with beneficial effects. Our results suggest that ethyl nitrite has the potential to improve the physiological status and organ function after brain death and to possibly expand the pool of organs available for donation.
